HK1221393A1 - 不用結腸切除術治療炎性腸病的方法和組合物 - Google Patents

不用結腸切除術治療炎性腸病的方法和組合物

Info

Publication number
HK1221393A1
HK1221393A1 HK16109488.2A HK16109488A HK1221393A1 HK 1221393 A1 HK1221393 A1 HK 1221393A1 HK 16109488 A HK16109488 A HK 16109488A HK 1221393 A1 HK1221393 A1 HK 1221393A1
Authority
HK
Hong Kong
Prior art keywords
colectomy
composition
inflammatory bowel
bowel disease
treating inflammatory
Prior art date
Application number
HK16109488.2A
Other languages
English (en)
Inventor
馬克．拉墨爾
斯蒂芬．
．巴迪拉克
蒂莫西．基恩
Original Assignee
Asana Medical Inc
Univ Of Pittsburgh Of The Commonwealth Syste
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asana Medical Inc, Univ Of Pittsburgh Of The Commonwealth Syste filed Critical Asana Medical Inc
Publication of HK1221393A1 publication Critical patent/HK1221393A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
    • A61L27/3633—Extracellular matrix [ECM]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/32—Surgical cutting instruments
    • A61B17/3205—Excision instruments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
    • A61L27/3629—Intestinal tissue, e.g. small intestinal submucosa
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3641—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the site of application in the body
    • A61L27/3679—Hollow organs, e.g. bladder, esophagus, urether, uterus, intestine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
    • A61L27/3834—Cells able to produce different cell types, e.g. hematopoietic stem cells, mesenchymal stem cells, marrow stromal cells, embryonic stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/52—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Transplantation (AREA)
  • Dermatology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Zoology (AREA)
  • Botany (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Developmental Biology & Embryology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medical Informatics (AREA)
  • Dispersion Chemistry (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Prostheses (AREA)
HK16109488.2A 2013-04-08 2016-08-10 不用結腸切除術治療炎性腸病的方法和組合物 HK1221393A1 (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201361809606P 2013-04-08 2013-04-08
US201361843286P 2013-07-05 2013-07-05
US201361901237P 2013-11-07 2013-11-07
PCT/US2014/033365 WO2014168964A1 (en) 2013-04-08 2014-04-08 Method and composition for treating inflammatory bowel disease without colectomy

Publications (1)

Publication Number Publication Date
HK1221393A1 true HK1221393A1 (zh) 2017-06-02

Family

ID=51689961

Family Applications (1)

Application Number Title Priority Date Filing Date
HK16109488.2A HK1221393A1 (zh) 2013-04-08 2016-08-10 不用結腸切除術治療炎性腸病的方法和組合物

Country Status (14)

Country Link
US (2) US20160045552A1 (zh)
EP (1) EP2983616B1 (zh)
JP (1) JP6461096B2 (zh)
KR (1) KR102129562B1 (zh)
CN (1) CN105358095B (zh)
AU (2) AU2014251110A1 (zh)
CA (1) CA2907774C (zh)
DK (1) DK2983616T3 (zh)
ES (1) ES2703785T3 (zh)
HK (1) HK1221393A1 (zh)
HU (1) HUE042704T2 (zh)
IL (1) IL241910B (zh)
PL (1) PL2983616T3 (zh)
WO (1) WO2014168964A1 (zh)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3119448B1 (en) 2014-03-21 2020-04-22 University of Pittsburgh- Of the Commonwealth System of Higher Education Methods for preparation of a terminally sterilized hydrogel derived from extracellular matrix
US20160000550A1 (en) * 2014-07-05 2016-01-07 Deborah Nagle Methods for treating diseases of the colon
CA3017747A1 (en) * 2016-03-14 2017-09-21 Regentys Corporation Method and composition for treating inflammatory bowel disease
US20190184060A1 (en) * 2016-08-19 2019-06-20 Regentys Corporation Extracellular matrix for tissue reconstruction of mucosal tissue
ES2931299T3 (es) 2017-03-02 2022-12-28 Univ Pittsburgh Commonwealth Sys Higher Education Hidrogel de matriz extracelular (ECM) y fracción soluble del mismo para su utilización en el tratamiento del cáncer
ES2957291T3 (es) 2017-03-02 2024-01-16 Univ Pittsburgh Commonwealth Sys Higher Education Hidrogel de ECM para el tratamiento de la inflamación esofágica
AU2018204259B2 (en) * 2017-06-29 2019-08-15 Covidien Lp Systems and methods for ablative treatment of irritable bowel disease
US11896228B2 (en) 2018-05-11 2024-02-13 Boston Scientific Scimed, Inc. Devices, systems, and methods for tissue resection
WO2019246444A1 (en) * 2018-06-21 2019-12-26 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Extracellular matrix (ecm) hydrogel as a submucosal fluid cushion
AU2019288591B2 (en) * 2018-06-21 2024-06-13 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Use of a urinary bladder ECM hydrogel as an esophageal submucosal fluid cushion
JP2021529024A (ja) * 2018-06-21 2021-10-28 ユニバーシティ オブ ピッツバーグ − オブ ザ コモンウェルス システム オブ ハイヤー エデュケイション 食道粘膜下流体クッションとしての細胞外マトリックス（ｅｃｍ）ヒドロゲルの使用

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5817662A (en) * 1992-11-09 1998-10-06 Cell Therapeutics, Inc. Substituted amino alkyl compounds
US5275826A (en) * 1992-11-13 1994-01-04 Purdue Research Foundation Fluidized intestinal submucosa and its use as an injectable tissue graft
US6974796B1 (en) * 1999-08-17 2005-12-13 Girsh Leonard S Therapeutic compositions for treatment of a damaged tissue
US5711969A (en) 1995-04-07 1998-01-27 Purdue Research Foundation Large area submucosal tissue graft constructs
US5554389A (en) 1995-04-07 1996-09-10 Purdue Research Foundation Urinary bladder submucosa derived tissue graft
SE9602644D0 (sv) * 1996-07-04 1996-07-04 Astra Ab New use
US6576265B1 (en) 1999-12-22 2003-06-10 Acell, Inc. Tissue regenerative composition, method of making, and method of use thereof
GB2423934B (en) * 2003-09-04 2007-11-28 Cook Biotech Inc Extracellular matrix composite materials, and manufacture and use thereof
WO2006119256A2 (en) * 2005-04-29 2006-11-09 Cook Biotech Incorporated Volumetric grafts for treatment of fistulae and related methods and systems
CA2637450A1 (en) * 2006-01-31 2007-08-09 Cook Biotech Incorporated Fistula grafts and related methods and systems for treating fistulae
US8084023B2 (en) 2007-01-22 2011-12-27 The Board Of Trustees Of The University Of Arkansas Maintenance and propagation of mesenchymal stem cells
AU2008223798A1 (en) * 2007-03-07 2008-09-12 Coloplast A/S Mesh comprising ECM
EP2022848A1 (en) * 2007-08-10 2009-02-11 Hubrecht Institut A method for identifying, expanding, and removing adult stem cells and cancer stem cells
CN104530233B (zh) * 2008-04-24 2018-01-30 株式会社遗传科技 细胞外基质蛋白的氨基酸序列rgd的特异性人源化抗体及其应用
CN102215883A (zh) * 2008-06-20 2011-10-12 库克生物科技公司 可压缩/可扩张医疗移植产品以及应用止血的方法
CN102256609B (zh) * 2008-07-30 2014-02-19 米辛瑟斯有限公司 衍生自前胃胞外基质的组织支架
CN101366976B (zh) * 2008-09-03 2012-08-29 陕西瑞盛生物科技有限公司 人源化异种细胞外基质材料及其制备方法
US8980296B2 (en) * 2009-02-18 2015-03-17 Cormatrix Cardiovascular, Inc. Compositions and methods for preventing cardiac arrhythmia
US20120165957A1 (en) * 2009-07-06 2012-06-28 Hanne Everland Biodegradable scaffold for soft tissue regeneration and use thereof
EP2480665A4 (en) * 2009-09-24 2013-04-03 Gene Techno Science Co Ltd HUMANIZED ANTIBODIES TO THE AMINO ACID SEQUENCE RGD OF EXTRACELLULAR MATRIX PROTEIN AND ITS USE
US8716438B2 (en) * 2009-10-09 2014-05-06 University of Pittsburgh—of the Commonwealth System of Higher Education Matricryptic ECM peptides for tissue reconstruction
WO2012002986A2 (en) * 2009-12-21 2012-01-05 The Regents Of The University Of California Decellularized and delipidized extracellular matrix and methods of use
JP2011246461A (ja) * 2010-04-27 2011-12-08 Mitsubishi Tanabe Pharma Corp 新規アミド誘導体を含有する医薬組成物
CN105311677B (zh) * 2010-05-25 2019-08-20 库克生物技术股份有限公司 用于医疗移植物的细胞接种的方法、基底和系统
WO2012003450A2 (en) * 2010-07-02 2012-01-05 The University Of North Carolina At Chapel Hill Biomatrix scaffolds
WO2012064606A2 (en) * 2010-11-10 2012-05-18 Wake Forest University Health Sciences Tissue-specific extracellular matrix with or without tissue protein components for cell culture
CN102552910B (zh) * 2010-12-31 2014-06-04 中国科学院上海生命科学研究院 细胞外基质蛋白1及其调节剂在制备过敏性疾病诊断或治疗药物中的应用
WO2012114334A1 (en) * 2011-02-24 2012-08-30 Ilan Ben Oren Hybrid catheter for endoluminal intervention
JP6552115B2 (ja) * 2013-03-15 2019-07-31 クック・メディカル・テクノロジーズ・リミテッド・ライアビリティ・カンパニーＣｏｏｋ Ｍｅｄｉｃａｌ Ｔｅｃｈｎｏｌｏｇｉｅｓ Ｌｌｃ 消化管病変を治療するための接着性医療製品及び方法

Also Published As

Publication number Publication date
KR102129562B1 (ko) 2020-07-03
CA2907774C (en) 2022-11-01
US20170112964A1 (en) 2017-04-27
AU2019203323A1 (en) 2019-05-30
IL241910B (en) 2021-04-29
ES2703785T3 (es) 2019-03-12
KR20160016778A (ko) 2016-02-15
CN105358095B (zh) 2020-11-20
AU2014251110A1 (en) 2015-11-26
JP2016520560A (ja) 2016-07-14
AU2019203323B2 (en) 2020-10-08
EP2983616A1 (en) 2016-02-17
WO2014168964A1 (en) 2014-10-16
HUE042704T2 (hu) 2019-07-29
DK2983616T3 (en) 2019-01-21
PL2983616T3 (pl) 2019-05-31
CA2907774A1 (en) 2014-10-16
CN105358095A (zh) 2016-02-24
US20160045552A1 (en) 2016-02-18
EP2983616A4 (en) 2016-08-31
EP2983616B1 (en) 2018-10-03
JP6461096B2 (ja) 2019-01-30

Similar Documents

Publication Publication Date Title
HK1221393A1 (zh) 不用結腸切除術治療炎性腸病的方法和組合物
HK1219512A1 (zh) 用於診斷和治療炎性腸病的方法
HK1221422A1 (zh) 診斷方法和用於治療成膠質細胞瘤的組合物
IL245281A0 (en) Methods and preparations for the treatment of cancer
SG10201707319UA (en) Compositions and methods for treating mpsi
EP2942703A4 (en) METHOD AND APPARATUS FOR APPLICATION SHARING
EP2958936A4 (en) METHOD AND COMPOSITIONS FOR TREATING CORI DISEASE
IL243928A0 (en) Preparations and methods for the treatment of complementary related conditions
PL3238707T3 (pl) Kompozycje i sposoby leczenia nadmiernej przepuszczalności jelit
HK1217650A1 (zh) 用於治療劇痛的組合物及方法
IL261738A (en) Method and composition for treating inflammatory bowel disease
HK1215373A1 (zh) 用於治療代謝疾病的方法和裝置
PL3084506T3 (pl) Endoskop i sposób jego użycia
GB201305414D0 (en) Method and composition
HK1224184A1 (zh) 用於治療炎性疾病的化合物、藥物組合物和方法
IL245602A0 (en) Compositions and methods for evaluating intestinal function
HK1225647A1 (zh) 用於治療癌症的組合物和方法
IL240469B (en) Preparations and methods for the treatment and repair of tendons
EP2968377A4 (en) COMPOSITIONS AND METHODS OF TREATING INFECTION DISEASES
SG10201710538XA (en) Compositions and methods for treating skin
GB201315846D0 (en) Method for treating or preventing hot flushes
IL245703A0 (en) Methods and preparations for the treatment of amyloid deposits
EP2970510A4 (en) METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER AND INFLAMMATORY DISEASES
HK1218249A1 (zh) 用於治療炎症性腸道疾病的化合物和方法
EP2968505A4 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF AUTOIMMUNE DISEASES